Cell cycle regulation and apoptosis

Annual Review of Physiology

Volumn 60, Issue , 1998, Pages 601-617

  King, K L ^a   Cidlowski, J A ^b  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^b NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

Author keywords

Cell cycle; Cell death; E2F; Lymphocytes; P53; PRb

Indexed keywords

CYCLIN DEPENDENT KINASE; CYCLINE; GLUCOCORTICOID; MYC PROTEIN; PROTEIN P53; RETINOBLASTOMA PROTEIN; TRANSCRIPTION FACTOR E2F;

APOPTOSIS; CELL CYCLE; CELL CYCLE G1 PHASE; CELL DEATH; CELL PROLIFERATION; HUMAN; LYMPHOCYTE; MITOSIS INHIBITION; NONHUMAN; PRIORITY JOURNAL; REVIEW;

ANIMALS; APOPTOSIS; CELL CYCLE; CELL DIVISION; GLUCOCORTICOIDS; HUMANS;

EID: 0031945458     PISSN: 00664278     EISSN: None     Source Type: Book Series    
DOI: 10.1146/annurev.physiol.60.1.601     Document Type: Review

References (22)

1. Schwartzman RA, Cidlowski JA. 1993. Apoptosis: the biochemistry and molecular biology of programmed cell death. Endocr. Rev. 14:133-50
2. Golstein P. 1997. Controlling cell death. Science 275:1081-82
3. Compton MM, Cidlowski JA. 1986. Rapid in vivo effects of glucocorticoids on the integrity of rat lymphocyte genomic deoxyribonucleic acid. Endocrinology 118:38-45
4. McDonnell TJ, Deane N, Platt M, Nunez G, Jaeger U, et al. 1989. bcl-2 immunoglobulin transgenic mice demonstrate extended B cell survival and follicular lympho-proliferation. Cell 57:79-88
5. 4a. McDonnell TJ, Korsmeyer SJ. 1991. Progression from lymphoid hyperplasia to high grade malignant lymphoma in mice transgenic for the t(14;18). Nature 349:254-56
6. 4b. Stasser A, Harris AW, Cory S. 1991. bcl-2 transgene inhibits T cell death and perturbs thymic self-censorship. Cell 67:889-99
7. Meikrantz W, Schlegel R. 1995. Apoptosis and the cell cycle. J. Cell. Biochem. 58:160-74
8. King KL, Schwartzman RA, Cidlowski JA. 1996. Apoptosis in life, death, and the cell cycle. Endocrinol. Metab. 3 Suppl. A:93-97
9. Murray A, Hunt T. 1993. The Cell Cycle. New York: Oxford Univ. Press. 251 pp.
10. Murray A. 1994. Cell cycle checkpoints. Curr. Opin. Cell Biol. 6:872-76
11. 8a. Morgan DO. 1995. Principles of Cdk regulation. Nature 374:131-34
12. 8b. Hunter T, Pines J. 1994. Cyclins and cancer II: cyclin D and Cdk inhibitors come of age. Cell 79:573-82
13. 8c. Fisher RP. 1997. Cdks and cyclins in transition. Curr. Opin. Gene Dev. 7:32-38
14. 8d. Harper JW, Elledge SJ. 1994. Cdk inhibitors in development and cancer. Curr. Opin. Gene Dev. 6:56-64
15. 8e. Xiong Y. 1996. Why are there so many Cdk inhibitors? Biochim. Biophys. Acta 1288:1-5
16. Amati B, Brooks MW, Levy N, Littlewood TD, Evan GI, et al. 1993. Oncogenic activity of the c-Myc protein requires dimerization with Max. Cell 72:233-45
17. Amati B, Littlewood TD, Evan GI, Land H. 1993. The c-Myc protein induces cell cycle progression and apoptosis through dimerization with Max. EMBO J. 12:5083-87
18. Eilers M, Schirm S, Bishop JM. 1991. The myc protein activates transcription of the α-prothymosin gene. EMBO J. 10:133-41
19. Galaktionov K, Chen X, Beach D. 1996. Cdc25 cell-cycle phosphatase as a target of c-myc. Nature 382:511-11
20. Heikkila R, Schwab G, Wickstrom E, Loke SL, Pluznik DH, et al. 1987. A c-myc antisense oligodeoxynucleotide inhibits entry into S phase but not progression from GO to G1. Nature 328:445-49
21. Askew D, Ashmun R, Simmons B, Cleveland J. 1991. Constitutive c-myc expression in IL-3 dependent myeloid cell line suppresses cycle cell arrest and accelerates apoptosis. Oncogene 6:1915-22
22. Evan G, Wyllie A, Gilbert C, Littlewood T, Land H, et al. 1992. Induction of apoptosis in fibroblasts by c-myc protein. Cell 63:119-25